These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22184192)

  • 41. Catatonia complicated by pneumothorax successfully treated with electroconvulsive therapy.
    Suzuki K; Katsura M; Ebina Y; Takano T; Matsuoka H
    J ECT; 2007 Dec; 23(4):284-5. PubMed ID: 18090705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ECT response in catatonia.
    Francis A; Fink M
    Am J Psychiatry; 1992 Apr; 149(4):581-2. PubMed ID: 1554062
    [No Abstract]   [Full Text] [Related]  

  • 44. [Depressive disorders in elderly: treatment possibilities rather than pharmacotherapy].
    Rosenberg O; Shoenfeld N; Kotler M; Dannon PN
    Harefuah; 2009 Feb; 148(2):109-13, 138. PubMed ID: 19627040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia.
    Prikryl R
    Neuro Endocrinol Lett; 2011; 32(2):121-6. PubMed ID: 21552191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment strategies for obsessive-compulsive disorder.
    Marazziti D; Consoli G
    Expert Opin Pharmacother; 2010 Feb; 11(3):331-43. PubMed ID: 20102301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
    Demitrack MA; Thase ME
    Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guideline recommendations for treatment of schizophrenia: the impact of managed care.
    Dickey B; Normand SL; Hermann RC; Eisen SV; Cortes DE; Cleary PD; Ware N
    Arch Gen Psychiatry; 2003 Apr; 60(4):340-8. PubMed ID: 12695310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The emerging use of technology for the treatment of depression and other neuropsychiatric disorders.
    Howland RH; Shutt LS; Berman SR; Spotts CR; Denko T
    Ann Clin Psychiatry; 2011 Feb; 23(1):48-62. PubMed ID: 21318196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chapters from the history of biological psychiatry: efforts made to increase the efficacy of electroconvulsive therapy].
    Gazdag G; Bitter I; Gerevich J; Ungvári G
    Psychiatr Hung; 2006; 21(5):351-9. PubMed ID: 17297197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcranial direct current stimulation (tDCS) for catatonic schizophrenia: a case study.
    Shiozawa P; da Silva ME; Cordeiro Q; Fregni F; Brunoni AR
    Schizophr Res; 2013 May; 146(1-3):374-5. PubMed ID: 23434501
    [No Abstract]   [Full Text] [Related]  

  • 53. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis.
    Dlabac-de Lange JJ; Knegtering R; Aleman A
    J Clin Psychiatry; 2010 Apr; 71(4):411-8. PubMed ID: 20361909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation.
    Chanpattana W; Chakrabhand ML; Kirdcharoen N; Tuntirungsee Y; Techakasem P; Prasertsuk Y
    J Med Assoc Thai; 1999 Jun; 82(6):558-68. PubMed ID: 10443077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia.
    Uçok A; Uçok G
    Convuls Ther; 1996 Jun; 12(2):108-12. PubMed ID: 8744171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practitioner review: electroconvulsive therapy in adolescents.
    Walter G; Rey JM; Mitchell PB
    J Child Psychol Psychiatry; 1999 Mar; 40(3):325-34. PubMed ID: 10190334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [History and present status of electroconvulsive therapy].
    Motohashi N
    Seishin Shinkeigaku Zasshi; 2007; 109(4):361-4. PubMed ID: 17561677
    [No Abstract]   [Full Text] [Related]  

  • 59. A review of continuation electroconvulsive therapy: application, safety, and efficacy.
    Trevino K; McClintock SM; Husain MM
    J ECT; 2010 Sep; 26(3):186-95. PubMed ID: 20805727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of electroshock in the era of psychopharmacology].
    Hippius H
    Encephale; 1975; 1(3):195-201. PubMed ID: 1227814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.